Pain and Split-belt Motor Learning in Older Adults

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-90
SponsorUniversity of Delaware

About this trial

The purpose of this research is to investigate the impact of acute pain, induced using an experimental pain paradigm of capsaicin paired with heat, on implicit locomotor learning and its retention in older adults.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 55-90 years old

Self-identifying as generally medically healthy

Able to read, write and speak English

Able to provide informed consent and attend all testing sessions

Disqualifiers

Resting heart rate < 50 or > 100 bpm

Resting blood pressure < 90/60 or > 165/95

Any history or current mental health condition, learning/developmental disability or cognitive impairment, including severe untreated ADD/ADHD, severe untreated anxiety, severe untreated depression, autism spectrum disorder, insomnia, mild cognitive impairment, etc. (Mild to moderate treated ADD/ADHD, anxiety, and/or depression are allowed.)

Score on the Montreal Cognitive Assessment (MoCA) <23

Trial design

Design model

Parallel

Treatments tested in this trial

  • Capsaicin 0.1% cream combined with a heat pack and applied to the lower leg

    Behavioral

    Capsaicin is applied to the skin of one of the lower legs, then covered with a heat pack that is secured to the leg with self-adhesive wrap.

Treatment groups

34 Participants
are divided into 2 treatment groups
Group A: No PainNo intervention 0 interventions
Group B: PainExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Learning magnitude

Step length asymmetry averaged over the last 25 strides of the practice period on day 1.

Time frame
End of day 1
2

Retention magnitude

Step length asymmetry averaged over the first 4 strides of the re-adaptation period on day 2.

Time frame
Beginning of day 2.
3

Forgetting index

Difference between retention magnitude and learning magnitude.

Time frame
End of day 1 and beginning of day 2.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.